The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's total assets are $92.98 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2023-12-31 | $97.15 B | 49.19% |
2022-12-31 | $65.12 B | 6.47% |
2021-12-31 | $61.16 B | -2.83% |
2020-12-31 | $62.94 B | 5.43% |
2019-12-31 | $59.70 B | -10.1% |
2018-12-31 | $66.41 B | -16.93% |
2017-12-31 | $79.95 B | 3% |
2016-12-31 | $77.62 B | 8.65% |
2015-12-31 | $71.44 B | 3.54% |
2014-12-31 | $69.00 B | 4.36% |
2013-12-31 | $66.12 B | 21.78% |
2012-12-31 | $54.29 B | 11.1% |
2011-12-31 | $48.87 B | 12.38% |
2010-12-31 | $43.48 B | 9.73% |
2009-12-31 | $39.62 B | 8.74% |
2008-12-31 | $36.44 B | 5.21% |
2007-12-31 | $34.63 B | 2.52% |
2006-12-31 | $33.78 B | 15.33% |
2005-12-31 | $29.29 B | 0.26% |
2004-12-31 | $29.22 B | 11.9% |
2003-12-31 | $26.11 B | 6.78% |
2002-12-31 | $24.45 B | 279.57% |
2001-12-31 | $6.44 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $171.96 B | 84.95% | ๐บ๐ธ USA |
Pfizer PFE | $221.09 B | 137.79% | ๐บ๐ธ USA |
AbbVie ABBV | $148.87 B | 60.11% | ๐บ๐ธ USA |
Eli Lilly LLY | $63.94 B | -31.23% | ๐บ๐ธ USA |
Biogen BIIB | $26.56 B | -71.43% | ๐บ๐ธ USA |
Gilead Sciences GILD | $56.29 B | -39.46% | ๐บ๐ธ USA |
Illumina ILMN | $10.04 B | -89.20% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $99.03 B | 6.51% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $73.94 B | -20.48% | ๐ฌ๐ง UK |